Dr. Schär AG   Report issue

For profit
Founded: South Tyrrolia Germany (1981)
Status: No NME R&D (1981)

Organization Overview

First Clinical Trial
2019
NCT04318509
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dr. Schär AG / SPA

Active Ingredients

Drugs in Other Trials (3)

amino acids (Freamine) (1 trial)

casein (1 trial)

oryza sativa (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3